🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, open-label, randomized (1:1) trial designed to evalu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12
Trial ID
NCT07689812
Treatments Being Tested
Primary Objective: 1\) To examine the impact of Circulating tumor DNA (ctD...
Status
Active Not Recruiting
Location
Trinitas Hospital and Comprehensive Cancer Center
Start Date
2022-04-06
Trial ID
NCT05333874
Treatments Being Tested
The primary objective of this study is to evaluate the effectiveness of zan...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-06
Trial ID
NCT07750158
Treatments Being Tested
The goal of this clinical trial is to assess if circulating tumor DNA, as a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07565857
Treatments Being Tested
The purpose of this study is to collect information about treatment recomme...
Status
Withdrawn
Location
Inova Schar Cancer Institute
Start Date
2022-08-23
Trial ID
NCT05379907
Treatments Being Tested
This randomized, phase 2 study will investigate the use of the Signatera ct...
Status
Terminated
Location
University of Florida
Start Date
2022-03-14
Trial ID
NCT04786600
Treatments Being Tested
This clinical trial compares minimal residual disease (MRD) testing with th...
Status
Recruiting
Location
CTCA at Western Regional Medical Center
Start Date
2025-08-29
Trial ID
NCT07125729
Treatments Being Tested
The BESPOKE CRC study will prospectively enroll patients who have undergone...
Status
Unknown
Location
San Carlos
Start Date
2020-04-24
Trial ID
NCT04264702
This is a randomized, open label, single-center, phase 2, randomized contro...
Status
Recruiting
Location
Smilow Cancer Center
Start Date
2026-06-02
Trial ID
NCT07282912
Treatments Being Tested
Heroes is a multicentre, national, non-randomized, open-label, phase 2 stud...
Status
Recruiting
Location
Centre Eugène marquis
Start Date
2025-01-25
Trial ID
NCT06450314
Treatments Being Tested